Wakayama Medical University · Department of Pharmacy / Faculty of Pharmaceutical Sciences

Research keywordsHepatocyte・vitro・In

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Considerations for developing CYP induction assays in hepatocytes: Insights from a multilaboratory study.2025 · European Journal of Cell Biology
• Converting suspension-type human primary hepatocytes to be plateable-type for use as an in vitro pharmacokinetics model2025 · Drug Metab. Pharmacokineti.
• Considerations for developing CYP induction assays in hepatocytes: Insights from a multilaboratory study.2025 · European Journal of Cell Biology 104(3) 151497-151497 2025年9月査読有り
• Converting suspension-type human primary hepatocytes to be plateable-type for use as an in vitro pharmacokinetics model2025 · Drug Metab. Pharmacokineti. 62 101044-101044 2025年6月査読有り

• 薬物安全性評価を目指した腸肝循環モデル型in vitro 肝毒性評価系の開発2026 · 令和7年度（第38回）中冨健康科学振興財団 「研究助成金」
• 灌流型小腸-肝臓2臓器連結デバイスを用いた胆汁鬱滞肝毒性評価系の展開2022 · 基盤研究(C)（一般）
• NTCP,BSEP強制発現HepG2細胞を用いた薬剤性胆汁鬱滞型肝障害評価2020 · 若手研究
• NTCP強制発現HepG2細胞によるin vitro薬剤性胆汁鬱滞型肝障害評価法2019 · 特別研究奨励費

• Official profile